Skip to content

Comparison of two different types of pain relieving techniques in patients undergoing hip fracture surgery

Comparison of continuous pericapsular nerve group block versus continuous fascia iliaca block in patients undergoing hip fracture surgery- a randomized double- blind study

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031148
Enrollment
50
Registered
2021-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur

Interventions

Intervention1: Continuous Pericapsular nerve group block (cPENG): Under USG guided cPENG with 20 ml 0.25% Ropivacaine followed by 0.2% ropivacaine at 5 ml/hr infusion Control Intervention1: Continuou

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)ASA physical status grade I and II patients 2)Greater than 18 years of age 3)Patients undergoing an operation for neck of femur, sub-capital and intertrochanteric fracture under spinal anaesthesia

Exclusion criteria

Exclusion criteria: 1)Patient refusal 2)ASA physical status III and IV 3)Known allergy to local anesthetics 4)Local site infection 5)Severe kidney and liver disease 6)Severe cardiac illness (NYHA Class III and IV) 7)Pre-operative opioid tolerance 8)Intrathecal morphine receivers 9)Postoperative epidural infusion receivers

Design outcomes

Primary

MeasureTime frame
To measure total fentanyl requirements in continuous pericapsular nerve group block versus continuous fascia iliaca blockTimepoint: 48 hours post operative

Secondary

MeasureTime frame
To compare the following between two groups 1) To assess NRS pain scores at rest and at 15° leg elevation 2) To compare block related adverse events, in terms of local anaesthetic systemic toxicity, hematoma formation and injection site infections. Timepoint: At 0,15 minutes,30 minutes during surgery and 2, 6, 12, 24 and 48 hours post surgery

Countries

India

Contacts

Public ContactKanil Ranjith Kumar

All Institute of Medical Sciences, New Delhi

kanil.aiims@gmail.com8800314575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026